Predictor | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
HR | 95 % CI | p | HR | 95 % CI | p | |
Age | 1.03 | 1.02–1.05 | < 0.001 | 1.02 | 1.01–1.04 | 0.009 |
Female sex | 0.86 | 0.67–1.10 | 0.220 | |||
Initial prednisone dose | 0.98 | 0.97–0.99 | 0.005 | 0.96 | 0.95–0.98 | < 0.0001 |
No. flares | 1.23 | 1.08–1.40 | 0.002 | 0.86 | 0.73–1.02 | 0.076 |
Peripheral involvement | 1.49 | 1.15–1.93 | 0.009 | 1.38 | 1.05–1.83 | 0.023 |
ESR | 1.00 | 0.99–1.01 | 0.146 | |||
CRP | 1.30 | 1.17–1.43 | < 0.001 | 1.29 | 1.14–1.45 | < 0.0001 |
Hemoglobin | 0.89 | 0.81–0.96 | 0.004 | 0.86 | 0.78–0.95 | 0.004 |
N-BP | 0.66 | 0.52–0.85 | 0.001 | 0.65 | 0.49–0.85 | 0.002 |
csDMARD | 0.93 | 0.71–1.23 | 0.610 | |||
Osteoporosis | 0.68 | 0.52–0.89 | 0.006 | 0.75 | 0.55–1.02 | 0.066 |
ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; csDMARD: conventional synthetic disease-modifying antirheumatic drugs; N-BP: amino bisphosphonates.